Search

everythinglearnresearchcommunity

for

Search:↓

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

DHT, a testosterone byproduct, causes male pattern baldness.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

NAFLD is common in women with PCOS and may signal metabolic syndrome.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.